AVBH AVBH R2K
$30.78
+55.45% 1Y
Market & Price
Market Cap
-
Current Price
$30.78
High / Low (52W)
$30.78 / $19.75
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$0.84
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$2.57B
Current Assets
-
Working Capital
-
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-61.93%
Profit 5Y
-193.04%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -61.9% CAGR over 5 years.
- Earnings shrank at -193.0% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 20.52M | 21.83M | -38.20M | 26.78M | 27.97M |
| Cost of Revenue | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Interest Expense | - | - | 15.17M | 15.35M | 14.60M | 13.31M | 12.54M |
| Pretax Income | - | - | 7.68M | 8.29M | -53.04M | 10.09M | 12.44M |
| Tax Provision | - | - | 2.25M | 2.50M | -15.30M | 3.14M | 3.42M |
| Net Income | 3.47M | - | 5.44M | 5.80M | -37.73M | 6.95M | 9.02M |
| Diluted EPS | 0.46 | 0.77 | 0.71 | 0.75 | - | 0.65 | 0.84 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 81.23M | 30.93M |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | - | - |
| Operating Income | - | - |
| EBITDA | - | - |
| Interest Expense | 67.22M | 58.45M |
| Pretax Income | 29.80M | -26.97M |
| Tax Provision | 8.79M | -7.42M |
| Net Income | 21.02M | -19.55M |
| Diluted EPS | 2.76 | -2.25 |
Compounded Sales Growth
| 5 Years: | -61.93% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -193.04% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +55.45% |
| 6 Months: | +19.49% |
| 3 Months: | +6.58% |
| 1 Month: | +4.52% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | - | 2.30B | 2.57B |
| Current Assets | - | - | - |
| Cash & Equivalents | - | 82.70M | 154.57M |
| Inventory | - | - | - |
| Receivables | - | - | - |
| Total Liabilities | - | 2.12B | 2.29B |
| Current Liabilities | - | - | - |
| Long Term Debt | - | 22.00M | 22.00M |
| Total Debt | - | 207.00M | 82.00M |
| Total Equity | 165.31M | 186.36M | 280.98M |
| Shares Outstanding | - | 7.91M | 10.95M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | 22.69M | 39.03M |
| Investing Cash Flow | -82.70M | -196.71M |
| Financing Cash Flow | 61.31M | 229.54M |
| Capital Expenditure | -47.00K | -93.00K |
| Free Cash Flow | 22.64M | 38.94M |
| Net Change in Cash | 1.30M | 71.87M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | - | - |
| Operating Margin % | - | - |
| Net Margin % | 25.9% | -63.2% |
| ROE % | 11.3% | -7.0% |
| ROCE % | - | - |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AVBH
No recent headlines available.